These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26451079)

  • 1. Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored.
    Wang Y; Sun S; Zhu J; Cui L; Zhang HL
    Mediators Inflamm; 2015; 2015():564098. PubMed ID: 26451079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
    Godschalk PC; Kuijf ML; Li J; St Michael F; Ang CW; Jacobs BC; Karwaski MF; Brochu D; Moterassed A; Endtz HP; van Belkum A; Gilbert M
    Infect Immun; 2007 Mar; 75(3):1245-54. PubMed ID: 17261613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics reveals Piccolo as a candidate serological correlate of recovery from Guillain-Barré syndrome.
    Mateos-Hernández L; Villar M; Doncel-Pérez E; Trevisan-Herraz M; García-Forcada Á; Ganuza FR; Vázquez J; de la Fuente J
    Oncotarget; 2016 Nov; 7(46):74582-74591. PubMed ID: 27776345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome.
    Nyati KK; Prasad KN
    Mediators Inflamm; 2014; 2014():758639. PubMed ID: 25614713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome.
    Li S; Yu M; Li H; Zhang H; Jiang Y
    Mediators Inflamm; 2012; 2012():260473. PubMed ID: 23091305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of Guillain-Barré syndrome.
    Wang Y; Zhang HL; Wu X; Zhu J
    Expert Rev Clin Immunol; 2016; 12(4):439-48. PubMed ID: 26642351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and diagnosis of Guillain-Barré syndrome - challenges and needs.
    Dash S; Pai AR; Kamath U; Rao P
    Int J Neurosci; 2015 Apr; 125(4):235-40. PubMed ID: 24731000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.
    Yuki N; Kuwabara S
    J Peripher Nerv Syst; 2007 Dec; 12(4):238-49. PubMed ID: 18042134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.
    Godschalk PC; Heikema AP; Gilbert M; Komagamine T; Ang CW; Glerum J; Brochu D; Li J; Yuki N; Jacobs BC; van Belkum A; Endtz HP
    J Clin Invest; 2004 Dec; 114(11):1659-65. PubMed ID: 15578098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Guillain-Barré syndrome.
    Fujimura H
    Handb Clin Neurol; 2013; 115():383-402. PubMed ID: 23931791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
    Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
    J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guillain-Barré syndrome: the International GBS Outcome Study].
    Kaida K; Kusunoki S
    Brain Nerve; 2014 Dec; 66(12):1496-502. PubMed ID: 25475036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sera from Guillain-Barré patients enhance leakage in blood-nerve barrier model.
    Kanda T; Yamawaki M; Mizusawa H
    Neurology; 2003 Jan; 60(2):301-6. PubMed ID: 12552049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics of Intravenous Injection of Monosialotetrahexosyl Ganglioside Sodium-Related Guillain-Barre Syndrome.
    Shi M; Zhu J; Deng H
    Front Neurol; 2019; 10():225. PubMed ID: 30930839
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain-Barré syndrome.
    Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS
    J Neurol Sci; 2014 May; 340(1-2):37-43. PubMed ID: 24607336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome: an update.
    Vucic S; Kiernan MC; Cornblath DR
    J Clin Neurosci; 2009 Jun; 16(6):733-41. PubMed ID: 19356935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
    Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
    Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
    Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review.
    Kaida K; Kusunoki S
    J Neuroimmunol; 2010 Jun; 223(1-2):5-12. PubMed ID: 20172612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.